I have accepted an invitation to speak at this year's Food & Drug Law Institute Advertising and Promotion conference about social media issues.
I'd like to solicit your input on topics for an interesting session. Of course, we'll have to cover OPDP's first social media guidance (see here and here), but what else do you think is particularly interesting or relevant to the participation of prescription-only products in this space.
Are there specific issues that you have not seen previously addressed? Have you seen anyone do something especially interesting in their use of social media that you think the industry as a whole needs to learn more about?
Send me your suggestions, or post a comment below.